Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Thursday, February 22, 2024 · 690,567,661 Articles · 3+ Million Readers

Clinical Trials Imaging Market is projected to experience a CAGR of 5.84% throughout the forecast period

ksi logo

The clinical trial imaging market is estimated to grow at a CAGR of 5.84% during the forecast period.

The clinical trial imaging market is estimated to grow at a CAGR of 5.84% during the forecast period.”
— Knowledge Sourcing Intelligence
NOIDA, UTTAR PARDESH, INDIA, November 24, 2023 / -- According to a new study published by Knowledge Sourcing Intelligence, the clinical trial imaging market is projected to grow at a CAGR of 5.84% between 2021 and 2028.

The key driving force behind the rapid growth of the clinical trial imaging market is the increasing chronic disease prevalence and favorable investment to improve cancer diagnostics. Also, as biotechnology advances, there is an increasing demand for sophisticated imaging technologies such as breast imaging to aid development. For instance, WCG Imaging Core Lab is the world leader in clinical trials. WCG's full-service medical imaging core lab offers extensive imaging services to pharmaceutical, biotechnology, and medical device companies across all therapeutic sectors.

Clinical trial imaging offers numerous benefits, including remote monitoring, improved accuracy, enhanced patient engagement, rare disease diagnosis, and regulatory support. The market is witnessing substantial growth due to increasing focus to improve the cancer therapeutic efficacy has positively impacted the demand for global clinical trial imaging.

Numerous product launches and technological advancements are taking place in the market. For instance, in November 2022, VIDA Diagnostics, Inc. the imaging intelligence leader, recently announced the release of VIDA Intelligence Portal 2.0. The newly updated platform improves clinical trial imaging operations by optimizing staff training, image data collection and quality, curation, and management. The new automated onboarding features in VIDA Intelligence Portal 2.0 greatly streamline the trial site acceptance process.

Access sample report or view details:

The clinical trial imaging market, based on service is segmented into, five main categories namely clinical trial design & consultation services, reading & analytical services, operational imaging services, system & technology support services, and project & data management.

The clinical trial imaging market, based on their application is segmented into, nine main categories namely NASH, CKD, diabetes, cardiovascular diseases, musculoskeletal, oncology, gastroenterology, pediatrics, and others.

The clinical trial imaging market, based on their end-users is segmented into, five main categories namely biotechnology & pharmaceutical companies, medical device manufacturers, academic & government research institutes, contract research organizations (CROs), and others.

North America is poised to experience substantial growth. Developed healthcare infrastructure inclusive of cutting-edge medical facilities, and a well-established regulatory framework in USA and Canada has majorly driven the market growth. For instance, the National Clinical Trials Network (NCTN) is a network of organizations and clinicians, that coordinates and supports cancer clinical trials at over 2,200 sites in the United States, and Canada. The economies are also witnessing strategic collaborations, for instance, in October 2022, American College of Radiology (ACR) collaborated with the Breast Cancer Research Foundation (BCRF) and GE Healthcare to launch the contrast-enhanced mammography imaging screening trial which will look to see if contrast-enhanced mammography improves breast cancer detection and reduces false-positive exams in women who have dense breasts.

The research includes coverage of IXICO plc, Navitas Life Sciences, Resonance Health, ProScan Imaging, Radiant Sage LLC, Medpace, Cardiovascular Imaging Technologies, WCG Clinical, BioTelemetry, and Median Technologies as the significant market players in the global clinical trial imaging market.

The market analytics report segments the clinical trial imaging market using the following criteria:

• By Service

o Clinical Trial Design & Consultation Services
o Reading & Analytical Services
o Operational Imaging Services
o System & Technology Support Services
o Project & Data Management

• By Application

o Diabetes
o Cardiovascular Diseases
o Musculoskeletal
o Oncology
o Gastroenterology
o Pediatrics
o Others

• By End-Use

o Biotechnology & Pharmaceutical companies
o Medical Devices Manufacturers
o Academic & Government Research Institutes
o Contract Research Organizations (CROs)
o Others

• By Geography

o North America

• United States
• Canada
• Mexico

o South America

• Brazil
• Argentina
• Others

o Europe

• United Kingdom
• Germany
• France
• Spain
• Others

o Middle East and Africa

• Saudi Arabia
• Israel
• Others

o Asia Pacific

• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

Companies Profiled:

• IXICO plc
• Navitas Life Sciences
• Resonance Health
• ProScan Imaging
• Radiant Sage LLC
• Medpace
• Cardiovascular Imaging Technologies
• WCG Clinical
• BioTelemetry
• Median Technologies

Explore More Reports:

• Intraoperative Imaging Market:
• Near Infrared Imaging Market:
• Minimally Invasive Imaging Market:

Ankit Mishra
Knowledge Sourcing Intelligence LLP
+1 850-250-1698
email us here
Visit us on social media:

Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release